Renhe Pharmacy Co (000650.SZ) Stock Price

Renhe Pharmacy Co Price

SZSE·CLOSED
5.24
​
Market closed

Revenue has compounded at 29.8% per year over the past 19 years to 3.54 B CNY. Earnings per share have grown at 3.8% per year over the last 19 years. Renhe Pharmacy Co's net margin stands at 11.1%, down from 13.5% several years earlier. Renhe Pharmacy Co currently offers a dividend yield of about 2.86%. The payout ratio is around 53% of earnings. The dividend has grown at 5.1% per year over the past 15 years.

Renhe Pharmacy Co stock price

Access this data via the Eulerpool API

Renhe Pharmacy Co business model & stock analysis

Renhe Pharmacy Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Nanchang, Jiangxi and currently employs 6,062 full-time employees. The firm is mainly engaged in medical industrial manufacturing and medical merchandising. The Company’s main products include capsules, granules, tablets, powder, injections, suppositories and ointment, among others. The firm is also involved in the wholesaling and retailing of health-related products. The firm distributes its products mainly in domestic market.

Frequently asked questions about Renhe Pharmacy Co

5 analysts currently rate the Renhe Pharmacy Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Renhe Pharmacy Co to generate revenue of 3.82 B CNY and earnings per share of 0.29 CNY.

Converted at the current exchange rate, the Renhe Pharmacy Co share trades at 0.69 EUR (5.24 CNY).

The Renhe Pharmacy Co share (000650.SZ) is listed on 1 stock exchanges, including: Shenzhen (000650.SZ).

The expected revenue of Renhe Pharmacy Co is 3.82 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Renhe Pharmacy Co is 405.98 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Renhe Pharmacy Co is currently 17.87. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Renhe Pharmacy Co stock.

The price-to-sales ratio (P/S) of Renhe Pharmacy Co is currently 1.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Renhe Pharmacy Co stock.

The Eulerpool Quality Score for Renhe Pharmacy Co is 4/10.

The ISIN of Renhe Pharmacy Co is CNE000000NF8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Renhe Pharmacy Co is 000650.SZ. The ticker symbol is used to trade Renhe Pharmacy Co shares on the stock exchange.

Fair ValueTerminal
5.29 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
583,375.45 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Dec 10, 1996
ISIN
CNE000000NF8
Cusip
Y4444S107
Market capitalization
7.34 B CNYMid Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
2.85
P/E ratio
P/Ee 2026
18.07
P/Ee 2027
16.37
P/Ee 2028
14.97
P/S
P/Se
1.90
EV/EBIT
10.23
P/B Ratio
1.16
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.23 %
Gross Margin
36.96 %
EBIT Margin
20.27 %
Net Margin
11.12 %
EPS (Earnings Per Share)
0.28 CNY
Net Debt / EBIT
—
Debt/Equity
0.00
Dividend
Dividend yield
2.86 %
Est. Dividend Yield
2.90 %
Payout Ratio
52.81 %
Dividend growth Ø5Y
8.71 %
Dividend payments per year
1
Dividend paid since
9 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 5, 2026, 9:44 AM

Renhe Pharmacy Co Peer Group

Renhe Pharmacy Co Ticker

SHZ · 000650.SZ

Renhe Pharmacy Co FIGI

000650:CH · BBG000P6CL08000650:CS · BBG000P6CLY1000650:C2 · BBG00F136DF7

All fundamentals and in-depth analysis of Renhe Pharmacy Co

Our stock analysis for Renhe Pharmacy Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Renhe Pharmacy Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.